Online citations, reference lists, and bibliographies.
← Back to Search

Encountering The Antibiotic Resistance By Bioactive Components And Therapies: Probiotics, Phytochemicals And Phages

S. A. Rasool, Muhammad Salman Rasool, Munazza Ajaz
Published 2021 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
This paper references
10.3168/JDS.S0022-0302(90)78747-4
Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans.
S. Gilliland (1990)
10.1128/aem.63.7.2747-2753.1997
The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo
M. Bernet-Camard (1997)
10.1128/AEM.64.11.4573-4580.1998
Antagonistic Activity againstHelicobacter Infection In Vitro and In Vivo by the HumanLactobacillus acidophilus Strain LB
M. Coconnier (1998)
10.1128/AEM.65.9.3763-3766.1999
The Scientific Basis for Probiotic Strains ofLactobacillus
G. Reid (1999)
10.1128/CMR.12.4.564
Plant Products as Antimicrobial Agents
M. M. Cowan (1999)
10.1159/000007660
Effect of Whey-Based Culture Supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori Infection in Humans
P. Michetti (1999)
10.1093/ajcn/69.5.1052s
Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut.
M. Collins (1999)
10.1046/j.1365-2672.1999.00950.x
Purification and characterization of a bacteriocin produced by Lactobacillus acidophilus IBB 801
M. Zamfir (1999)
10.1016/S0924-8579(00)00188-6
Helicobacter pylori: ureA, cagA and vacA expression during conversion to the coccoid form.
F. Sisto (2000)
10.1038/35021219
Molecular mechanisms that confer antibacterial drug resistance
C. Walsh (2000)
10.1128/AEM.66.3.1152-1157.2000
Antagonistic Activity of Lactobacillus acidophilus LB against Intracellular Salmonella enterica Serovar Typhimurium Infecting Human Enterocyte-Like Caco-2/TC-7 Cells
M. Coconnier (2000)
10.1046/j.1365-2958.2000.02029.x
Functional analysis of promoters involved in quorum sensing‐based regulation of bacteriocin production in Lactobacillus
P. A. Risøen (2000)
10.1111/J.1574-6976.2000.TB00534.X
Class IIa bacteriocins: biosynthesis, structure and activity.
S. Ennahar (2000)
10.1139/W01-013
Comparison of the activity spectra against pathogens of bacterial strains producing a mutacin or a lantibiotic.
H. Morency (2001)
10.3402/FNR.V45I0.1790
HEALTH EFFECTS OF PROBIOTICS AND PREBIOTICS. A LITERATURE REVIEW ON HUMAN STUDIES
H. Andersson (2001)
10.1016/S0168-1605(01)00465-2
Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid.
M. Ogawa (2001)
10.1111/J.1574-6976.2001.TB00579.X
Lantibiotics: structure, biosynthesis and mode of action.
O. McAuliffe (2001)
10.1016/S0305-1978(01)00025-4
Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species.
F. Stermitz (2001)
10.1021/NP000554F
In vitro cytotoxicity of the protoberberine-type alkaloids.
K. Iwasa (2001)
H Andersson (2001)
10.1093/JAC/DKF159
In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori.
K. Tominaga (2002)
10.1016/S0378-8741(01)00350-6
The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis.
S. Newton (2002)
K Tominaga (2002)
10.1128/IAI.71.11.6199-6204.2003
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
J. M. Loeffler (2003)
10.1021/JF0302714
Isoflavones as potentiators of antibacterial activity.
C. Morel (2003)
10.4315/0362-028X-66.1.3
Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria.
Tae-Seok Kim (2003)
10.1016/S0960-894X(03)00316-0
Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors.
F. Stermitz (2003)
10.1016/S0167-7799(03)00085-4
Bacterial replacement therapy: adapting 'germ warfare' to infection prevention.
J. Tagg (2003)
10.1128/JB.186.14.4808-4812.2004
Identification of a Broadly Active Phage Lytic Enzyme with Lethal Activity against Antibiotic-Resistant Enterococcus faecalis and Enterococcus faecium
P. Yoong (2004)
10.1007/s00018-004-4301-y
Identification and characterization of a highly thermostable bacteriophage lysozyme
R. Lavigne (2004)
10.1016/J.IJFOODMICRO.2003.07.001
In vitro assessment of the upper gastrointestinal tolerance of potential probiotic dairy propionibacteria.
Y. Huang (2004)
10.1023/A:1020582211262
Production of class II bacteriocins by lactic acid bacteria; an example of biological warfare and communication
V. Eijsink (2004)
10.1055/S-2004-835860
Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus.
S. Gibbons (2004)
10.1021/NP030409C
Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria.
G. Belofsky (2004)
10.1128/AAC.49.7.2934-2940.2005
Phage P68 Virion-Associated Protein 17 Displays Activity against Clinical Isolates of Staphylococcus aureus
M. Takáč (2005)
10.1021/NP0497447
Natural and synthetic 2,2-dimethylpyranocoumarins with antibacterial activity.
E. Melliou (2005)
10.1128/AEM.71.10.6115-6120.2005
A Lactobacillus acidophilus Strain of Human Gastrointestinal Microbiota Origin Elicits Killing of Enterovirulent Salmonella enterica Serovar Typhimurium by Triggering Lethal Bacterial Membrane Damage
Marie-Hélène Coconnier-Polter (2005)
10.1074/JBC.M502723200
Structure and Lytic Activity of a Bacillus anthracis Prophage Endolysin*
L. Y. Low (2005)
10.1128/CDLI.12.12.1378-1386.2005
Lactobacillus johnsonii La1 Attenuates Helicobacter pylori-Associated Gastritis and Reduces Levels of Proinflammatory Chemokines in C57BL/6 Mice
D. Sgouras (2005)
10.1016/J.TIM.2005.08.007
Bacteriophage lytic enzymes: novel anti-infectives.
V. Fischetti (2005)
10.1016/J.ADDR.2005.04.002
Bacterial resistance to antibiotics: enzymatic degradation and modification.
G. Wright (2005)
10.1111/j.1348-0421.2005.tb03732.x
Remarkable Synergies between Baicalein and Tetracycline, and Baicalein and β‐Lactams against Methicillin‐Resistant Staphylococcus aureus
M. Fujita (2005)
10.1093/PS/84.4.655
Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens.
W. Huff (2005)
10.1128/AEM.71.10.6008-6013.2005
pH-, Lactic Acid-, and Non-Lactic Acid-Dependent Activities of Probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium
D. Fayol-Messaoudi (2005)
10.1128/JB.187.20.7161-7164.2005
The Recombinant Phage Lysin LysK Has a Broad Spectrum of Lytic Activity against Clinically Relevant Staphylococci, Including Methicillin-Resistant Staphylococcus aureus
S. O'flaherty (2005)
10.1021/JF051765Z
Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin.
Byeoung-Soo Park (2005)
10.1128/AAC.49.7.2914-2920.2005
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
M. D. Navarro-Martínez (2005)
M Fujita (2005)
A Anadon (2005)
10.1016/J.IJFOODMICRO.2006.01.029
Lactobacillus spp. with in vitro probiotic properties from human faeces and traditional fermented products.
M. G. Vizoso Pinto (2006)
10.1128/AAC.50.2.810-812.2006
Piperine, a Phytochemical Potentiator of Ciprofloxacin against Staphylococcus aureus
I. Khan (2006)
10.1111/j.1365-2672.2006.02857.x
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero‐ and uropathogens
P. Hütt (2006)
10.1007/s00253-006-0517-0
Antimicrobial activity of resin acid derivatives
S. Savluchinske-Feio (2006)
10.1099/MIC.0.28690-0
Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli.
D. Gordon (2006)
10.1016/J.AJIC.2005.12.009
Novel ways of preventing antibiotic-resistant infections: what might the future hold?
M. Roghmann (2006)
10.1016/J.FOODCHEM.2005.01.003
Carvone: Why and how should one bother to produce this terpene
C. Carvalho (2006)
10.1016/J.RESMIC.2005.09.002
Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds.
L. Makras (2006)
10.1111/J.1574-6968.2006.00250.X
Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid.
S. D. De Keersmaecker (2006)
MC Roghmann (2006)
10.1128/mmbr.00036-06
Colicin Biology
E. Cascales (2007)
10.1039/B516237H
Microcins, gene-encoded antibacterial peptides from enterobacteria.
S. Duquesne (2007)
10.1016/J.JPBA.2007.02.018
Evaluation of the antimicrobial mode of berberine by LC/ESI-MS combined with principal component analysis.
Zhi-biao Yi (2007)
10.1007/s00284-007-9094-4
Purification and Partial Characterization of Novel Bacteriocin L23 Produced by Lactobacillusfermentum L23
L. Pascual (2007)
10.1007/s00005-007-0039-1
Terpenes: substances useful in human healthcare
R. Paduch (2007)
10.1248/CPB.55.912
Steroidal alkaloids from Holarrhena antidysenterica (L.) WALL.
Neeraj Kumar (2007)
10.1111/j.1365-2672.2007.03293.x
The Lactobacillus plantarum strain ACA‐DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar Typhimurium
D. Fayol-Messaoudi (2007)
Characterization and purification of acidocin 1B, a bacteriocin produced by Lactobacillus acidophilus GP1B.
K. Han (2007)
10.1111/j.1365-2672.2007.03416.x
Quality of silages from Italian farms as attested by number and identity of microbial indicators
F. Rossi (2007)
10.1099/MIC.0.2007/012831-0
Making sense of quorum sensing in lactobacilli: a special focus on Lactobacillus plantarum WCFS1.
M. Sturme (2007)
10.1592/phco.27.2.227
Emerging Options for Treatment of Invasive, Multidrug‐Resistant Staphylococcus aureus Infections
R. Drew (2007)
KS Han (2007)
10.1016/J.IJANTIMICAG.2007.10.009
In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin.
Yun Cai (2008)
10.1111/j.1574-695X.2008.00454.x
Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host.
B. Sánchez (2008)
10.1128/AEM.02474-07
Genotypic Diversity, Antimicrobial Resistance, and Virulence Factors of Human Isolates and Probiotic Cultures Constituting Two Intraspecific Groups of Enterococcus faecium Isolates
V. Vankerckhoven (2008)
10.1093/jac/dkn178
Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
D. Lechner (2008)
10.1017/S1466252308001576
Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs
R. Johnson (2008)
10.1111/j.1574-6968.2008.01308.x
The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
S. C. Becker (2008)
10.1124/pr.107.07110
Sortase as a Target of Anti-Infective Therapy
A. Maresso (2008)
10.1128/AAC.00732-07
AdeIJK, a Resistance-Nodulation-Cell Division Pump Effluxing Multiple Antibiotics in Acinetobacter baumannii
L. Damier-Piolle (2008)
10.1111/j.1574-6968.2008.01152.x
Tail-associated structural protein gp61 of Staphylococcus aureus phage phi MR11 has bifunctional lytic activity.
M. Rashel (2008)
10.1016/j.anaerobe.2007.11.003
Three Lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitro.
Cheng-Chih Tsai (2008)
10.1093/jac/dkn088
Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
Ashwani Kumar (2008)
10.1111/j.1574-6968.2008.01176.x
Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity.
R. Pridmore (2008)
10.1021/bi7018546
Berberine targets assembly of Escherichia coli cell division protein FtsZ.
Prerna N. Domadia (2008)
10.1016/j.mimet.2008.01.014
The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
C. Carey (2008)
10.1016/j.ijantimicag.2008.06.010
D-Alanine:D-alanine ligase as a new target for the flavonoids quercetin and apigenin.
Dalei Wu (2008)
10.1139/w08-022
Safety evaluation of two bacterial strains used in Asian probiotic products.
T. Tompkins (2008)
10.1128/AEM.00991-08
Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L. reuteri DSM 17938
A. Rosander (2008)
10.1016/j.anaerobe.2008.02.001
Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
J. Spinler (2008)
M Anas (2008)
10.2741/3445
Microbial diversity in the human intestine and novel insights from metagenomics.
M. Ventura (2009)
10.1099/jmm.0.009407-0
Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori.
K. Ryan (2009)
10.1097/MPG.0b013e3181924d1e
Isolation, Identification, and Characterization of Small Bioactive Peptides From Lactobacillus GG Conditional Media That Exert Both Anti-Gram-negative and Gram-positive Bactericidal Activity
R. Lu (2009)
10.1016/J.FOODCONT.2008.03.007
Antimicrobial properties of selected essential oils in vapour phase against foodborne bacteria
L. Nedorostová (2009)
10.1016/j.ijantimicag.2008.10.022
A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins.
T. Smyth (2009)
10.3390/molecules14030939
Antimicrobial and Antioxidant Activities of Coumarins from the Roots of Ferulago campestris (Apiaceae)
A. Basile (2009)
10.1111/j.1365-2672.2009.04180.x
The antimicrobial effects of glucosinolates and their respective enzymatic hydrolysis products on bacteria isolated from the human intestinal tract
A. Aires (2009)
10.1186/1757-4749-1-14
Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG
K. Burkholder (2009)
10.1016/j.ijfoodmicro.2009.03.005
Enzymatic inhibition by allyl isothiocyanate and factors affecting its antimicrobial action against Escherichia coli O157:H7.
F. Luciano (2009)
10.1111/j.1365-2672.2008.04052.x
Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products
E. Simova (2009)
LACTIC ACID BACTERIA AGAINST PATHOGENIC MICROBES
M. Petrova (2009)
10.2174/187220809787172678
Production and application of bacteriophage and bacteriophage-encoded lysins.
N. D. Courchesne (2009)
Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community.
Jose L. Raygada (2009)
10.1016/S0895-3988(10)60018-9
Antibiotic resistance of probiotic strains of lactic acid bacteria isolated from marketed foods and drugs.
Chang Liu (2009)
M Petrova (2009)
JL Raygada (2009)
10.2174/138920110790725311
Phage choice, isolation, and preparation for phage therapy.
J. Gill (2010)
10.1016/j.anaerobe.2009.11.002
In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.
M. Matu (2010)
10.1016/j.ijfoodmicro.2010.04.001
Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria.
K. Palaniappan (2010)
10.1038/ijo.2010.50
The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years
R. Luoto (2010)
10.1371/journal.pone.0013745
Genetic Evidence for Inhibition of Bacterial Division Protein FtsZ by Berberine
Jaroslaw M. Boberek (2010)
10.2174/1573406411006030174
Antimicrobial activity of phenolics and glucosinolate hydrolysis products and their synergy with streptomycin against pathogenic bacteria.
M. Saavedra (2010)
10.1099/mic.0.044057-0
Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions.
B. Sánchez (2010)
10.1111/j.1365-2672.2010.04762.x
Towards a compatible probiotic–antibiotic combination therapy: assessment of antimicrobial resistance in the Japanese probiotics
A. Hammad (2010)
10.1016/j.resmic.2010.06.007
Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp. enterica serovar typhimurium 1344 in a common medium under different environmental conditions.
C. Marianelli (2010)
10.4161/bbug.1.1.9818
Recombinant bacteriophage lysins as antibacterials
M. Fenton (2010)
10.1016/j.ijfoodmicro.2010.02.031
Probiotics and prebiotics in animal feeding for safe food production.
F. Gaggìa (2010)
10.1016/j.ijfoodmicro.2010.04.029
Synergy between the phage endolysin LysH5 and nisin to kill Staphylococcus aureus in pasteurized milk.
P. García (2010)
10.1111/j.1574-6968.2009.01887.x
Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens.
F. Atassi (2010)
10.1017/S0007114509993497
The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics.
C. Koning (2010)
10.4161/gmic.1.3.12127
Safety assessment of probiotics for human use
M. Sanders (2010)
Evaluation of the effects of galbanic acid from Ferula szowitsiana and conferol from F. badrakema, as modulators of multi-drug resistance in clinical isolates of Escherichia coli and Staphylococcus aureus
B. S. Fazly Bazzaz (2010)
10.1016/j.plasmid.2009.12.004
Sequence analysis of plasmid pIR52-1 from Lactobacillus helveticus R0052 and investigation of its origin of replication.
K. Hagen (2010)
10.1371/journal.pone.0011748
The Complete Genome of Propionibacterium freudenreichii CIRM-BIA1T, a Hardy Actinobacterium with Food and Probiotic Applications
H. Falentin (2010)
10.1080/10412905.2010.9700321
Antibacterial Activities Against Staphylococcus aureus of Terpene Alcohols With Aliphatic Carbon Chains
Naoko Togashi (2010)
10.1111/J.1574-6976.2009.00208.X
The extracellular biology of the lactobacilli
M. Kleerebezem (2010)
10.1038/nrmicro2297
Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens
S. Lebeer (2010)
BS Fazly Bazzaz (2010)
Antimicrobial activity of different Lactobacillus species against multi- drug resistant clinical isolates of Pseudomonas aeruginosa
H. Jamalifar (2011)
10.1186/1471-2180-11-226
A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein
V. Paul (2011)
10.1016/j.jep.2011.06.039
Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
B. Chan (2011)
10.1128/AAC.01664-10
Effect of Antibiotic Treatment on the Intestinal Metabolome
L. Antunes (2011)
10.1128/AAC.00418-11
Impairment of Swimming Motility by Antidiarrheic Lactobacillus acidophilus Strain LB Retards Internalization of Salmonella enterica Serovar Typhimurium within Human Enterocyte-Like Cells
V. Lievin-Le Moal (2011)
10.1111/j.1574-6976.2010.00247.x
Quinolones: from antibiotics to autoinducers
S. Heeb (2011)
10.1016/j.micres.2011.02.006
Antimicrobial activity against Shigella sonnei and probiotic properties of wild lactobacilli from fermented food.
Ying-chun Zhang (2011)
10.1186/1471-2180-11-138
Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88
Lorena Rodríguez (2011)
10.4161/bact.1.2.15845
Phage treatment of human infections
S. Abedon (2011)
10.1111/j.1365-2672.2010.04884.x
Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi‐drug resistant Salmonella enterica serovar Typhimurium DT104 in mice
T. Asahara (2011)
10.1016/j.ijfoodmicro.2011.04.026
New insights into physiology and metabolism of Propionibacterium freudenreichii.
A. Thierry (2011)
10.1016/j.bmcl.2011.09.097
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
L. Casu (2011)
10.1371/journal.pone.0023045
Benzyl Isothiocyanate, a Major Component from the Roots of Salvadora Persica Is Highly Active against Gram-Negative Bacteria
A. Sofrata (2011)
10.3920/BM2011.0032
A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011.
L. Foster (2011)
10.1016/j.ijfoodmicro.2010.12.029
Probiotic assessment of Enterococcus faecalis CP58 isolated from human gut.
C. Nueno-Palop (2011)
10.1146/annurev-micro-090110-102908
Motility and chemotaxis in Campylobacter and Helicobacter .
Paphavee Lertsethtakarn (2011)
10.2131/JTS.36.277
The mechanism of action of sanguinarine against methicillin-resistant Staphylococcus aureus.
B. Obiang-Obounou (2011)
10.1016/j.ijfoodmicro.2011.06.011
The quorum sensing luxS gene is induced in Lactobacillus acidophilus NCFM in response to Listeria monocytogenes.
Saloomeh Moslehi-Jenabian (2011)
10.1128/AEM.05576-11
Bacteriocin Production: a Probiotic Trait?
A. Dobson (2011)
H Jamalifar (2011)
10.1038/srep00233
Impact of Intestinal Microbiota on Intestinal Luminal Metabolome
M. Matsumoto (2012)
10.1080/14786419.2010.537268
Antimicrobial activity of the methanolic bark extract of Holarrhena pubescens (Buch. Ham), its fractions and the pure compound conessine
B. S. Siddiqui (2012)
10.3168/jds.2011-4756
Safety of a probiotic cheese containing Lactobacillus plantarum Tensia according to a variety of health indices in different age groups.
E. Songisepp (2012)
10.1002/anie.201103110
Terpene biosynthesis: modularity rules.
E. Oldfield (2012)
10.1093/jac/dks005
Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
Jes Gitz Holler (2012)
10.1128/JB.01638-12
Complete Genome Sequence of Lactobacillus helveticus R0052, a Commercial Probiotic Strain
T. Tompkins (2012)
10.1111/j.1574-695X.2012.00977.x
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro.
Elizabeth M Ryan (2012)
10.1016/j.ijfoodmicro.2011.05.025
Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.
Eileen F. O'Shea (2012)
10.1186/1471-2180-13-15
Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture
E. Muñoz-Atienza (2012)
10.1111/j.1600-065X.2011.01081.x
Innate immune signaling in defense against intestinal microbes
Melissa A. Kinnebrew (2012)
10.4161/gmic.21215
Microbial ecology and host-microbiota interactions during early life stages
M. Collado (2012)
10.1271/bbb.110921
Reduction of Overall Helicobacter pylori Colonization Levels in the Stomach of Mongolian Gerbil by Lactobacillus johnsonii La1 (LC1) and Its in Vitro Activities against H. pylori Motility and Adherence
H. Isobe (2012)
10.1021/jf302245m
Assessment of the probiotic potential of a dairy product fermented by Propionibacterium freudenreichii in piglets.
Fabien J. Cousin (2012)
10.1016/j.fm.2012.05.002
Purification and characterization of a new bacteriocin active against Campylobacter produced by Lactobacillus salivarius SMXD51.
Soumaya Messaoudi (2012)
10.1038/nrmicro2690
Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa
P. Bron (2012)
10.1093/jac/dkr510
Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression.
G. Mitchell (2012)
10.4161/gmic.24627
Mobile genetic elements of the human gastrointestinal tract
Eileen Broaders (2013)
10.1016/j.bbrc.2013.03.126
Urease from Helicobacter pylori is inactivated by sulforaphane and other isothiocyanates.
J. Fahey (2013)
10.1002/bies.201300018
Replenishing our defensive microbes
L. Ursell (2013)
10.1007/s11101-013-9334-0
Allium ursinum: botanical, phytochemical and pharmacological overview
D. Sobolewska (2013)
ANTIMICROBIAL STUDIES OF ALLICIN AND AJOENE
F. Mairaj (2013)
10.1111/j.1863-2378.2012.01510.x
Interaction of Campylobacter spp. and Human Probiotics in Chicken Intestinal Mucus
M. Ganan (2013)
10.4265/BIO.18.163
Antimicrobial activity of isothiocyanates (ITCs) extracted from horseradish (Armoracia rusticana) root against oral microorganisms.
Ho-won Park (2013)
10.1038/ncomms3151
Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota.
Yongfei Hu (2013)
10.1111/1574-6976.12030
The complex microbiota of raw milk.
L. Quigley (2013)
10.21608/EAJBSG.2013.16636
Antimicrobial activity of probiotic bacteria
S. Ali (2013)
10.1016/j.anaerobe.2013.05.001
Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system.
E. Meader (2013)
10.3389/fmicb.2013.00202
Antibiotic resistance in probiotic bacteria
M. Gueimonde (2013)
10.1016/j.ejmech.2013.03.016
Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
Zhu-Ping Xiao (2013)
10.4161/cib.23095
Chemical warfare
R. Samuels (2013)
10.1016/j.it.2013.01.005
Regulation of intestinal homeostasis and immunity with probiotic lactobacilli.
P. van Baarlen (2013)
10.1038/ni.2611
The role of the immune system in governing host-microbe interactions in the intestine
E. Brown (2013)
10.3390/ijerph10072643
Antimicrobial Resistance in the Food Chain: A Review
Claire Verraes (2013)
10.3389/fmicb.2013.00087
The human microbiome as a reservoir of antimicrobial resistance
J. Penders (2013)
10.1038/nrmicro2937
Bacteriocins — a viable alternative to antibiotics?
P. Cotter (2013)
10.1021/jf304586j
Ungeremine and Its hemisynthesized analogues as bactericides against Flavobacterium columnare.
K. Schrader (2013)
10.1007/s00217-013-2066-y
Dairy propionibacterium strains with potential as biopreservatives against foodborne pathogens and their tolerance–resistance properties
Z. Yuksekdag (2013)
10.1038/nri3535
Microbiota-mediated colonization resistance against intestinal pathogens
C. Buffie (2013)
10.1002/jsfa.6222
Using lytic bacteriophages to eliminate or significantly reduce contamination of food by foodborne bacterial pathogens.
A. Sulakvelidze (2013)
10.1016/j.fitote.2013.07.015
NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.
Somendu K Roy (2013)
10.4049/jimmunol.1203100
Role of the Gut Microbiota in the Development and Function of Lymphoid Cells
N. Kamada (2013)
10.1099/mic.0.067678-0
Compound(s) secreted by Lactobacillus casei strain Shirota YIT9029 irreversibly and reversibly impair the swimming motility of Helicobacter pylori and Salmonella enterica serovar Typhimurium, respectively.
V. Le Moal (2013)
10.3109/1040841X.2012.723675
Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics
Lorena Rodríguez-Rubio (2013)
10.1186/1471-2180-14-25
A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota
F. Fouhy (2013)
F Rehman (2013)
EFSA (2013)
FS Ali (2013)
10.3389/fmicb.2013.00202
Antibiotic resistance in probiotic bacteria
M. Gueimonde (2013)
10.1016/j.ejmech.2014.04.037
Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms.
Zhu-Ping Xiao (2014)
10.3389/fmicb.2014.00217
Antibiotic alternatives: the substitution of antibiotics in animal husbandry?
Guyue Cheng (2014)
10.1016/j.ijfoodmicro.2014.04.004
Resveratrol against Arcobacter butzleri and Arcobacter cryaerophilus: activity and effect on cellular functions.
S. Ferreira (2014)
10.1002/bit.25019
A high‐throughput screen for antibiotic drug discovery
Thomas C. Scanlon (2014)
10.1093/jac/dku173
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Tania Mareike Viertel (2014)
10.1016/j.resmic.2014.07.001
Thymol disrupts the membrane integrity of Salmonella ser. typhimurium in vitro and recovers infected macrophages from oxidative stress in an ex vivo model.
A. Chauhan (2014)
10.1007/s11101-014-9366-0
Compounds from Allium species with cytotoxic and antimicrobial activity
V. Lanzotti (2014)
10.1094/MPMI-09-13-0262-R
Plant defense stimulation by natural isolates of bacillus depends on efficient surfactin production.
H. Cawoy (2014)
10.3390/ijms151119552
Antimicrobial Activity of Isothiocyanates from Cruciferous Plants against Methicillin-Resistant Staphylococcus aureus (MRSA)
C. Dias (2014)
10.4161/gmic.27916
The abundance of antibiotic resistance genes in human guts has correlation to the consumption of antibiotics in animal
Yongfei Hu (2014)
10.1016/J.FOODCONT.2014.05.047
Natural products as antimicrobial agents
R. Gyawali (2014)
10.1128/CMR.00080-13
Anti-Infective Activities of Lactobacillus Strains in the Human Intestinal Microbiota: from Probiotics to Gastrointestinal Anti-Infectious Biotherapeutic Agents
V. Lievin-Le Moal (2014)
10.1016/j.mycmed.2014.01.063
Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi.
S. Abbaszadeh (2014)
10.1186/1471-2180-14-172
In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii
J. Betts (2014)
10.1089/FPD.2013.1627
The mechanism of antimicrobial activity of sophoraflavanone B against methicillin-resistant Staphylococcus aureus.
MunSu-Hyun (2014)
10.22038/IJBMS.2014.2407
Study of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant (MDR) bacteria isolated from urinary tract infections (UTIs)
A. Naderi (2014)
10.1016/S1473-3099(14)70780-7
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.
T. V. Van Boeckel (2014)
10.1128/AAC.02166-13
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
G. Daikos (2014)
10.1146/annurev-micro-091213-113052
Altered egos: antibiotic effects on food animal microbiomes.
H. Allen (2014)
10.1021/jm401685f
Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.
Feixia Duan (2014)
10.1093/infdis/jit637
Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia
R. Schuch (2014)
10.1016/j.ijantimicag.2014.06.001
Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities.
Tim Cushnie (2014)
D Zou (2014)
A Naderi (2014)
R Gyawali (2014)
10.2217/fmb.15.8
Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
Y. Briers (2015)
10.3402/mehd.v26.25876
Food-producing animals and their health in relation to human health
G. Tellez (2015)
10.1016/j.phymed.2015.01.002
Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells.
Sara Abdelfatah (2015)
10.1016/j.mimet.2015.04.011
High-throughput screening assays for antibacterial and antifungal activities of Lactobacillus species.
Raffael C. Inglin (2015)
10.1038/ismej.2014.106
Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology
Molly K. Gibson (2015)
10.3389/fmicb.2015.00685
Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases
N. Varankovich (2015)
10.1099/mic.0.082362-0
The antibacterial properties of isothiocyanates.
Virginie Dufour (2015)
10.1073/pnas.1503141112
Global trends in antimicrobial use in food animals
T. V. Van Boeckel (2015)
10.3109/03639045.2014.920025
Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus
B. Khameneh (2015)
10.1371/journal.pone.0119564
Eugenol: A Phyto-Compound Effective against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Strain Biofilms
M. Yadav (2015)
10.1007/s00253-015-6853-1
Microencapsulation of new probiotic formulations for gastrointestinal delivery: in vitro study to assess viability and biological properties
G. D'Orazio (2015)
10.1007/s12602-015-9195-5
Screening, Characterization and In Vitro Evaluation of Probiotic Properties Among Lactic Acid Bacteria Through Comparative Analysis
S. M. Devi (2015)
10.3390/ijerph120505177
Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms
Wei Jia (2015)
10.18433/J30894
Application of iChip to Grow "Uncultivable" Microorganisms and its Impact on Antibiotic Discovery.
Rinzhin T Sherpa (2015)
10.1016/j.phymed.2014.11.019
Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
Issam Al-Ani (2015)
10.1128/AAC.00068-15
Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor
R. Card (2015)
10.1186/s40104-015-0018-z
The application of antimicrobial peptides as growth and health promoters for swine
Hao Xiao (2015)
10.3389/fpls.2015.00414
Glucosinolate-derived isothiocyanates impact mitochondrial function in fungal cells and elicit an oxidative stress response necessary for growth recovery
B. Calmes (2015)
10.1371/journal.pone.0121313
Bactericidal Activity of Curcumin I Is Associated with Damaging of Bacterial Membrane
Poonam Tyagi (2015)
10.1111/IJFS.12934
Effect of carvacrol and thymol on Salmonella spp. biofilms on polypropylene
V. S. Amaral (2015)
10.5851/kosfa.2015.35.4.473
In vitro Characterization of Bacteriocin Produced by Lactic Acid Bacteria Isolated from Nem Chua, a Traditional Vietnamese Fermented Pork
K. Pilasombut (2015)
10.3390/antibiotics4020160
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
L. Mcfarland (2015)
10.1093/jac/dkv109
Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure
M. Webber (2015)
10.1080/21597081.2015.1062590
Antimicrobial bacteriophage-derived proteins and therapeutic applications
Dwayne R. Roach (2015)
10.1007/s00253-015-6436-1
Deciphering the role of coumarin as a novel quorum sensing inhibitor suppressing virulence phenotypes in bacterial pathogens
J. A. Gutiérrez-Barranquero (2015)
10.1007/s12602-015-9199-1
Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463
S. Senan (2015)
10.1038/nrd4675
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
David Brown (2015)
10.1016/J.LWT.2015.01.019
Cholesterol-lowering effects of a putative probiotic strain Lactobacillus plantarum EM isolated from kimchi
Eun A Choi (2015)
10.1016/j.compbiolchem.2015.09.006
Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action
K. Patel (2015)
10.1038/nrd4675
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
David Brown (2015)
R Ranjbar (2015)
Y Briers (2015)
G Téllez (2015)
10.3109/13880209.2015.1091483
The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans
J. Shao (2016)
10.1016/j.tips.2016.05.001
Natural Products as a Source for Novel Antibiotics.
M. Moloney (2016)
10.1016/j.micpath.2016.08.008
Antibacterial and efflux pump inhibitors of thymol and carvacrol against food-borne pathogens.
Hanene Miladi (2016)
10.1016/j.mimet.2016.07.027
A review of current methods using bacteriophages in live animals, food and animal products intended for human consumption.
I. Cooper (2016)
10.5812/jjm.18952
Efficacy of Locally Isolated Lactic Acid Bacteria Against Antibiotic-Resistant Uropathogens
A. Manzoor (2016)
10.3109/07388551.2014.993587
Phage lytic proteins: biotechnological applications beyond clinical antimicrobials
Lorena Rodríguez-Rubio (2016)
10.1126/science.aad3292
Multidrug evolutionary strategies to reverse antibiotic resistance
M. Baym (2016)
10.3831/KPI.2016.19.032
Effect of Catechins, Green tea Extract and Methylxanthines in Combination with Gentamicin Against Staphylococcus aureus and Pseudomonas aeruginosa
B. S. Fazly Bazzaz (2016)
10.3390/molecules21081084
Antibacterial Activity and Membrane-Disruptive Mechanism of 3-p-trans-Coumaroyl-2-hydroxyquinic Acid, a Novel Phenolic Compound from Pine Needles of Cedrus deodara, against Staphylococcus aureus
Yanping Wu (2016)
10.1016/j.ijantimicag.2016.05.014
Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli.
Manesh Kumar (2016)
10.1111/jam.13247
Reduced susceptibilities to biocides and resistance to antibiotics in food‐associated bacteria following exposure to quaternary ammonium compounds
C. Soumet (2016)
10.1038/nature18597
Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion
F. Faber (2016)
10.1099/jgv.0.000428
Identification and characterization of HolGH15: the holin of Staphylococcus aureus bacteriophage GH15.
Jun Song (2016)
10.1016/j.micpath.2016.02.009
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them.
B. Khameneh (2016)
10.5772/63141
Antimicrobial Effect of Probiotics against Common Pathogens
S. Fijan (2016)
10.3389/fmicb.2016.01983
Addressing the Antibiotic Resistance Problem with Probiotics: Reducing the Risk of Its Double-Edged Sword Effect
Ivan C Imperial (2016)
10.3389/fmicb.2016.01177
Bacteriophage Procurement for Therapeutic Purposes
B. Weber-Dąbrowska (2016)
10.1002/med.21346
Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases
Qiwei Jiang (2016)
10.1016/j.drudis.2016.04.001
Modulating antibiotic activity towards respiratory bacterial pathogens by co-medications: a multi-target approach.
N. Vandevelde (2016)
10.1089/mdr.2015.0194
Holarrhena antidysenterica Extract and Its Steroidal Alkaloid, Conessine, as Resistance-Modifying Agents Against Extensively Drug-Resistant Acinetobacter baumannii.
Thanyaluck Siriyong (2016)
10.2174/1573407212666161014132503
Bioautography detection of antimicrobial compounds from the essential oil of salvia pachystachys
A. Shakeri (2016)
10.1515/biolog-2016-0073
Efflux pump inhibitory activity of flavonoids isolated from Alpinia calcarata against methicillin-resistant Staphylococcus aureus
Harmandeep Kaur Randhawa (2016)
10.3389/fmicb.2016.01403
Antibacterial Activities of Wasabi against Escherichia coli O157:H7 and Staphylococcus aureus
Zhongjing Lu (2016)
Protective Role of Lactobacillus acidophilus against vaginal infection with Trichomonas vaginalis
Z. Valadkhani (2016)
10.1016/J.INDCROP.2015.11.059
Isolation and identification of an antibacterial compound from Diplotaxis harra (Forssk.) Boiss
Roudaina Benzekri (2016)
Z Valadkhani (2016)
B Weber-Dabrowska (2016)
Z Lu (2016)
B Khameneh (2016)
NM Vandevelde (2016)
L Rodríguez-Rubio (2016)
10.1093/femspd/ftx009
Antimicrobial activity of Lactobacillus salivarius and Lactobacillus fermentum against Staphylococcus aureus
Mi-Sun Kang (2017)
10.3382/ps/pew367
Effect of Propionibacterium freudenreichii on Salmonella multiplication, motility, and association with avian epithelial cells1
Divek V T Nair (2017)
10.3390/microorganisms5020024
Dairy Propionibacteria: Versatile Probiotics
Houem Rabah (2017)
10.1159/000473872
Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with the Topical Endolysin Staphefekt SA.100: A Report of 3 Cases
J. Totté (2017)
10.1021/acs.chemrev.7b00283
Natural Products as Platforms To Overcome Antibiotic Resistance.
Sean E Rossiter (2017)
10.1111/jam.13315
Anti‐Campylobacter activity of resveratrol and an extract from waste Pinot noir grape skins and seeds, and resistance of Camp. jejuni planktonic and biofilm cells, mediated via the CmeABC efflux pump
A. Klančnik (2017)
10.1016/j.micres.2016.12.003
Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity.
R. Barbieri (2017)
10.22037/IJPR.2017.2014
Evaluation of the Synergistic Effect of Tomatidine with Several Antibiotics against Standard and Clinical Isolates of Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa and Escherichia coli
R. Soltani (2017)
10.1016/j.ejmech.2017.09.014
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
R. Cannalire (2017)
10.3390/molecules22101711
Diallylthiosulfinate (Allicin), a Volatile Antimicrobial from Garlic (Allium sativum), Kills Human Lung Pathogenic Bacteria, Including MDR Strains, as a Vapor
Jana Reiter (2017)
10.1007/s13205-016-0591-7
Antibacterial effects of Lactobacillus isolates of curd and human milk origin against food-borne and human pathogens
C. Sharma (2017)
10.1016/j.bioorg.2017.05.011
Comparison of seven structurally related coumarins on the inhibition of Quorum sensing of Pseudomonas aeruginosa and Chromobacterium violaceum.
R. E. D’Almeida (2017)
10.1016/S1875-5364(17)30080-8
Antibacterial steroidal alkaloids from Holarrhena antidysenteriaca.
Lina Zhou (2017)
10.1016/j.ejmech.2017.04.018
Antibacterial activity of N-methylbenzofuro[3,2-b]quinoline and N-methylbenzoindolo[3,2-b]-quinoline derivatives and study of their mode of action.
N. Sun (2017)
Inhibitory effects of reserpine against efflux pump activity of antibiotic resistance bacteria
Sridevi Dhanarani (2017)
10.3390/molecules22071098
Antibacterial Activities of Pyrenylated Coumarins from the Roots of Prangos hulusii
N. Tan (2017)
10.3389/fmicb.2017.00957
Efficacy of Phage Therapy in Controlling Rabbit Colibacillosis and Changes in Cecal Microbiota
J. Zhao (2017)
10.1016/j.bj.2017.06.008
Probiotic potential of Lactobacilli with antagonistic activity against pathogenic strains: An in vitro validation for the production of inhibitory substances
C. Prabhurajeshwar (2017)
R Soltani (2017)
LN Zhou (2017)
D Sridevi (2017)
C Prabhurajeshwar (2017)
10.1016/j.jsps.2018.03.004
Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli
A. G. Abdelhamid (2018)
10.3390/ph11020034
Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation
Callum J. Cooper (2018)
10.1007/s00253-018-8787-x
Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition
F. Reen (2018)
10.2174/1871526518666180806123230
Repurposing of Existing Statin drugs for treatment of Microbial Infections: How much Promising?
Ritika Rana (2018)
10.1038/s41598-018-26738-1
Multidrug resistant pathogens respond differently to the presence of co-pathogen, commensal, probiotic and host cells
A. Chan (2018)
10.4172/2155-6113-C1-026
Evolution of super-drug resistant microbial strains: Mechanisms and strategies for containment
pSheikh Ajaz Rasool Salman Rasool (2018)
10.3389/fmicb.2018.01475
Characterizing the Antimicrobial Function of a Dairy-Originated Probiotic, Propionibacterium freudenreichii, Against Multidrug-Resistant Salmonella enterica Serovar Heidelberg in Turkey Poults
D. Nair (2018)
10.1371/journal.pone.0192694
Lactobacillus plantarum lipoteichoic acid inhibits biofilm formation of Streptococcus mutans
K. Ahn (2018)
10.1128/CMR.00079-17
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
J. Rodríguez-Baño (2018)
10.1016/j.mycmed.2018.04.002
Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei.
A. Sharifzadeh (2018)
10.1007/s11101-018-9591-z
Comprehensive review of antimicrobial activities of plant flavonoids
Ireneusz Górniak (2018)
10.3389/fmicb.2018.01952
Coumarin Reduces Virulence and Biofilm Formation in Pseudomonas aeruginosa by Affecting Quorum Sensing, Type III Secretion and C-di-GMP Levels
Yunhui Zhang (2018)
10.22038/AJP.2018.15338.1607
In vitro evaluation of antibacterial activity of verbascoside, lemon verbena extract and caffeine in combination with gentamicin against drug-resistant Staphylococcus aureus and Escherichia coli clinical isolates
B. S. Fazly Bazzaz (2018)
BS Fazly Bazzaz (2018)
10.1002/ptr.6208
Antibacterial activity of flavonoids and their structure–activity relationship: An update review
F. Farhadi (2019)
Prevalence and antibiotic resistance profiles of Gram negative bacilli associated with urinary tract infections (UTIs) in Karachi, Pakistan.
Muhammad Salman Rasool (2019)
10.3389/fmicb.2019.00789
Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae
Chi-Chung Chen (2019)
10.1080/07391102.2018.1458654
Synergy of clavine alkaloid ‘chanoclavine’ with tetracycline against multi-drug-resistant E. coli
G. Dwivedi (2019)
10.1186/s13756-019-0559-6
Review on plant antimicrobials: a mechanistic viewpoint
B. Khameneh (2019)
10.1016/J.YCLNEX.2018.10.001
Evaluation of antimicrobial properties and their substances against pathogenic bacteria in-vitro by probiotic Lactobacilli strains isolated from commercial yoghurt
C. Prabhurajeshwar (2019)
10.1186/s12906-019-2470-3
Invitro synergistic activity of lactic acid bacteria against multi-drug resistant staphylococci
J. Bhola (2019)
F Farhadi (2019)
MS Rasool (2019)
SA Rasool (2019)
10.26502/avsm.013
In-Vitro Antibacterial Activity of Probiotic Against Human Multidrug Resistant Pathogens
B. Saud (2020)
10.1155/2020/3548618
Antibacterial Activity of Lactobacillus Strains Isolated from Mongolian Yogurt against Gardnerella vaginalis
Zhixiang Qian (2020)



Semantic Scholar Logo Some data provided by SemanticScholar